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Bronchopulmonary dysplasia (BPD), a chronic lung dis-
ease of preterm infants, is characterized by impaired
alveolar growth and pathologic vascularization.
Aims
To investigate the role of Fgf10 in alveologenesis and
during/after hyperoxic lung injury.
Methods
1) 10 weeks old Fgf10+/- mice (50% Fgf10 expression
compared to WT) in normoxic condition: Lung function
and morphometric analysis.
2) BPD model:
a) Fgf10+/- and Fgf10+/+ mice were exposed to 85% O2
from P0-P8. Morphometric analysis and a-Actin/vWF
staining were performed at P3.
b) Rosa26rtTA/+;tet(O)Fgf10 (gain-of-function) mice
were exposed to 85% O2 from P0-P8. From P9-P45 the
pups were exposed to normoxia and fed either with nor-
mal food (control) or doxycycline food (experimental) to
activate the transgene Fgf10. Morphometric analysis was
carried out at P45.
3) Tolerance study: Rosa26rtTA/+;tet(O)Fgf10 and WT
mice (both 10 weeks old) were exposed to doxycycline
for 2 weeks. Then survival rate, histology, Ki67 and
TUNEL staining were performed.
Results
1) Fgf10+/- mice under normoxic condition have worse
lung function and lung structure compared to WT mice.
2) All Fgf10+/- mice die from hyperoxic injury due to
increased lung injury and vascular malformation.
3) Overexpression of Fgf10 after hyperoxic injury leads
to improvement of lung structure compared to control
group without overexpression.
4) Fgf10 overexpression after hyperoxic injury does
not increase mortality and side effects (weight loss,
mucosal proliferation due to hypercellularity with no
impact on apoptosis) are reversible.
Conclusion
Fgf10 attenuates hyperoxic lung injury, is well tolerated
and should be further studied as a potential therapeutic
for BPD.
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